$13.2 Billion is the total value of Carlyle Group Inc.'s 13 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PPD | PPD Inc | $2,108,548,000 | +10.6% | 55,722,733 | 0.0% | 15.96% | -37.5% | |
| ONEM | 1Life Healthcare Inc | $531,984,000 | -10.5% | 13,612,681 | 0.0% | 4.02% | -49.4% | |
| VTRU | Vitru Ltd | $92,760,000 | +0.7% | 6,246,471 | 0.0% | 0.70% | -43.1% | |
| TALO | Talos Energy Inc | $59,718,000 | +46.1% | 4,960,000 | 0.0% | 0.45% | -17.4% | |
| ONE | Onesmart Intl Ed Group Ltdsponsored ads | $21,065,000 | -29.5% | 7,860,000 | 0.0% | 0.16% | -60.2% | |
| DOC | Physicians Rlty Tr | $10,387,000 | -0.7% | 587,838 | 0.0% | 0.08% | -43.6% | |
| SMHI | Seacor Marine Hldgs Inc | $6,119,000 | +96.7% | 1,147,989 | 0.0% | 0.05% | +9.5% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
| Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
| eFFECTOR Therapeutics, Inc. | August 18, 2023 | 4,829,891 | 7.8% |
| Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
| Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
| EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
| SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
| Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
| NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
| QuidelOrtho Corp | June 06, 2022 | 12,460,183 | 18.6% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-05-13 |
| 10-Q | 2024-05-07 |
| 13F-HR | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
| 4 | 2024-05-03 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.